MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis
暂无分享,去创建一个
S. Akira | T. Gingeras | J. Drenkow | G. Schoolnik | K. Takeda | D. Schnappinger | C. Nathan | A. Ding | S. Ehrt | S. Shi | M. Fuortes | E. Block | Shuangping Shi
[1] T. van der Poll,et al. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. , 2003, The Journal of clinical investigation.
[2] C. Sousa. Faculty Opinions recommendation of TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. , 2003 .
[3] C. Figdor,et al. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. , 2003, Arthritis and rheumatism.
[4] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[5] J. Witztum,et al. Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.
[6] O. Schwartz,et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.
[7] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[8] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[9] R. Flavell,et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors , 2002, Nature.
[10] S. Akira,et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.
[11] L. Kwak,et al. Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.
[12] E. Unanue,et al. MyD88-Dependent but Toll-Like Receptor 2-Independent Innate Immunity to Listeria: No Role for Either in Macrophage Listericidal Activity1 , 2002, The Journal of Immunology.
[13] S. Akira,et al. Critical Roles of Myeloid Differentiation Factor 88-Dependent Proinflammatory Cytokine Release in Early Phase Clearance of Listeria monocytogenes in Mice1 , 2002, The Journal of Immunology.
[14] R. Vabulas,et al. Cutting Edge: Myeloid Differentiation Factor 88 Deficiency Improves Resistance Against Sepsis Caused by Polymicrobial Infection1 , 2002, The Journal of Immunology.
[15] R. Modlin,et al. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. , 2002, Current opinion in immunology.
[16] M. Fenton,et al. The role of Toll-like receptors in immunity against mycobacterial infection. , 2002, Microbes and infection.
[17] A. Sher,et al. Cutting Edge: MyD88 Is Required for Resistance to Toxoplasma gondii Infection and Regulates Parasite-Induced IL-12 Production by Dendritic Cells1 , 2002, The Journal of Immunology.
[18] J. Roman,et al. M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[19] H. Schild,et al. Heat shock proteins as ligands of toll-like receptors. , 2002, Current topics in microbiology and immunology.
[20] L. Kwak,et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. , 2002, Science.
[21] S. Akira,et al. Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.
[22] M. Fenton,et al. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages , 2001, Annals of the rheumatic diseases.
[23] T. Gingeras,et al. Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.
[24] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[25] Amer A. Beg,et al. An Essential Role of the NF-κB/Toll-Like Receptor Pathway in Induction of Inflammatory and Tissue-Repair Gene Expression by Necrotic Cells1 , 2001, The Journal of Immunology.
[26] J. Keane,et al. Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses1 , 2001, The Journal of Immunology.
[27] J. Bijlsma. Diagnosis and nonsurgical management of osteoarthritis , 2001, Annals of the rheumatic diseases.
[28] T. Gingeras,et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. , 2001, The Journal of experimental medicine.
[29] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[30] P. Srivastava,et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.
[31] E. Cesarman,et al. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.
[32] T. van der Poll,et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. , 2000, The Journal of infectious diseases.
[33] I. Orme,et al. Interleukin-6 Induces Early Gamma Interferon Production in the Infected Lung but Is Not Required for Generation of Specific Immunity to Mycobacterium tuberculosisInfection , 2000, Infection and Immunity.
[34] Y. Iwakura,et al. Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice , 2000, Laboratory Investigation.
[35] S. Teitelbaum,et al. Tumor necrosis factor alpha regulates alpha(v)beta5 integrin expression by osteoclast precursors in vitro and in vivo. , 2000, Endocrinology.
[36] Y. Iwakura,et al. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. , 2000, Laboratory investigation; a journal of technical methods and pathology.
[37] Shi Wei,et al. Tumor Necrosis Factor α Regulatesα vβ5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo1. , 2000, Endocrinology.
[38] D. Golenbock,et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.
[39] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[40] C. Janeway,et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. , 1998, Molecular cell.
[41] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[42] J. Ernst,et al. Macrophage Receptors for Mycobacterium tuberculosis , 1998, Infection and Immunity.
[43] S. Kaufmann,et al. Copyright © 1997, American Society for Microbiology Lethal Tuberculosis in Interleukin-6-Deficient Mutant Mice , 1997 .
[44] M. Wainberg,et al. Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[45] T. Miyata,et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. , 1996, The Journal of clinical investigation.
[46] A. Tomasz,et al. CD14 is a pattern recognition receptor. , 1994, Immunity.
[47] W. Fanslow,et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.
[48] T. Lee,et al. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. , 1993, The Journal of clinical investigation.
[49] Terry D. Lee,et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.
[50] M. Fresno,et al. Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism , 1992 .
[51] M. Fresno,et al. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. , 1992, European journal of immunology.
[52] D. Riches,et al. Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state. , 1991, The Journal of biological chemistry.
[53] J. Sypek,et al. Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane , 1991, The Journal of experimental medicine.
[54] P. Bailly,et al. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells , 1990, The Journal of experimental medicine.
[55] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.
[56] S. Haskill,et al. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. , 1988, Journal of immunology.
[57] E. Unanue,et al. Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide. , 1987, Journal of immunology.
[58] R. Mertelsmann,et al. Activation of human macrophages. Comparison of other cytokines with interferon-gamma , 1984, Journal of Experimental Medicine.
[59] T. Hamilton,et al. The cell biology of macrophage activation. , 1984, Annual review of immunology.
[60] M. Meltzer. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. , 1981, Journal of immunology.
[61] S. Russell,et al. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. , 1981, Journal of immunology.
[62] H. Chapman,et al. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s). , 1979, Advances in experimental medicine and biology.
[63] C. Nathan,et al. ALTERATIONS OF MACROPHAGE FUNCTIONS BY MEDIATORS FROM LYMPHOCYTES , 1971, The Journal of experimental medicine.
[64] G. Mackaness. THE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVO , 1969, The Journal of experimental medicine.